A Heart That Has Grown Too Large to Work Properly
Dilated cardiomyopathy (DCM) is the second most common acquired heart disease in dogs, and in large and giant breeds it is frequently the first. The heart muscle weakens and the chambers enlarge, impairing the organ's ability to pump blood efficiently. By the time clinical signs appear, the disease may already be advanced — which is why understanding which breeds are vulnerable and what early indicators look like can genuinely be life-saving.
What Happens to the Heart in DCM
In a healthy heart, the muscular walls contract powerfully with each beat to propel blood through the circulation. In DCM, the myocardium — the heart muscle itself — becomes thin and weak. The chambers, particularly the left ventricle, dilate to compensate, but dilation ultimately makes function worse rather than better. Cardiac output falls, fluid backs up into the lungs or abdomen, and the heart becomes prone to dangerous arrhythmias. The disease typically progresses through a long preclinical phase during which the dog appears outwardly healthy, followed by a faster decline once clinical signs emerge.
Breeds Most Commonly Affected
DCM has a clear hereditary component in several breeds, though the precise genetic mechanisms are still being characterised in many of them.
High-Risk Large and Giant Breeds
- Dobermann Pinscher: Carries the highest prevalence of any breed; some studies suggest over half of all Dobermanns will develop DCM given a long enough lifespan.
- Irish Wolfhound: Frequently affected and often at a relatively young age.
- Great Dane: Prone to both DCM and associated arrhythmias.
- Boxer: Develops a variant known as arrhythmogenic right ventricular cardiomyopathy, which shares features with DCM.
- Cocker Spaniel: One of the few smaller breeds with a documented hereditary form of DCM.
- Newfoundland and Scottish Deerhound: Both appear on surveillance lists maintained by veterinary cardiologists.
Diet-Associated DCM
From around 2018, reports emerged linking DCM to grain-free and boutique diets high in legumes, pulses, and potatoes. The US Food and Drug Administration investigated multiple cases, and while a causal mechanism has not been definitively confirmed, many veterinary cardiologists advise caution with diets that place legumes prominently in the ingredient list. If you are feeding a grain-free diet to a large or at-risk breed, this is worth discussing with your vet.
Recognising the Warning Signs
The preclinical phase of DCM can last months to years. Regular cardiac screening is the most reliable way to detect the disease early in predisposed breeds. However, owners should also know the signs that suggest disease has progressed to a symptomatic stage.
Early and Moderate Signs
- Exercise intolerance: the dog tires unusually quickly or refuses activities it previously enjoyed.
- Increased resting respiratory rate or occasional episodes of rapid breathing at rest.
- A soft cough, particularly after lying down or early in the morning.
- Reduced appetite and unexplained weight loss.
- Occasional weakness or brief episodes of wobbling — potentially caused by arrhythmias.
Advanced and Emergency Signs
- Severe breathlessness or respiratory distress caused by fluid in the lungs (pulmonary oedema).
- Marked abdominal distension from fluid accumulation (ascites).
- Sudden collapse or syncope, which may indicate a serious arrhythmia.
- Blue or grey gums indicating poor oxygenation.
Advanced signs require emergency veterinary care. Dogs in acute heart failure deteriorate rapidly.
Diagnosis and Screening
Diagnosis involves a combination of tools. Chest radiographs reveal cardiac enlargement and pulmonary congestion. An echocardiogram — ultrasound imaging of the heart — is the definitive diagnostic test, allowing direct measurement of chamber dimensions and assessment of contractile function. An electrocardiogram (ECG) identifies arrhythmias, which in Dobermanns in particular may be present years before the structural disease becomes apparent on echocardiography. Some cardiologists recommend Holter monitoring (a 24-hour ECG recording) as part of Dobermann screening specifically because of this dissociation.
For at-risk breeds, the Dobermann Health UK scheme and similar breed health programmes recommend annual cardiac screening beginning at a young age. Ask your vet or a board-certified veterinary cardiologist about the recommended screening protocol for your breed.
Treatment and Prognosis
There is no cure for DCM, but medical management can meaningfully extend life and improve quality of life. The landmark PROTECT study demonstrated that the drug pimobendan, when given during the preclinical phase to Dobermanns with echocardiographic evidence of DCM, delayed the onset of clinical heart failure by a median of over nine months. Additional medications — including ACE inhibitors, diuretics, and antiarrhythmic drugs — are introduced as the disease progresses, guided by the dog's individual presentation.
Prognosis varies considerably by breed and stage of disease at diagnosis. Dogs identified in the preclinical phase generally fare better than those first diagnosed in congestive heart failure.
What Owners of At-Risk Breeds Should Do
- Enrol in a breed-specific cardiac screening programme before your dog shows any symptoms — early detection changes outcomes.
- Count your dog's resting respiratory rate regularly (a rate consistently above 30 breaths per minute in a sleeping dog warrants a vet call).
- Discuss diet with your vet, particularly if you are currently feeding a grain-free or legume-heavy diet.
- Report any episodes of exercise intolerance, coughing, or brief collapse promptly rather than waiting to see if they recur.
- Never adjust cardiac medications without veterinary guidance.
DCM is a serious disease, but it is one where early detection and evidence-based medicine make a genuine, measurable difference.